Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
  1. Home
  2. Publications
  3. Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

Authors:
  • VPVerena Paulitschke
    Verena Paulitschke
  • Walter Berger
    Walter Berger
  • PPPhilipp Paulitschke
    Philipp Paulitschke
  • EHElisabeth Hofstätter
    Elisabeth Hofstätter
  • BKBernhard Knapp
    Bernhard Knapp
  • RDRuth Dingelmaier-Hovorka
    Ruth Dingelmaier-Hovorka
  • DFDagmar Födinger
    Dagmar Födinger
  • WJWalter Jäger
    Walter Jäger
  • TSThomas Szekeres
    Thomas Szekeres
  • AMAnastasia Meshcheryakova
    Anastasia Meshcheryakova
  • ABAndrea Bileck
    Andrea Bileck
  • CPChristine Pirker
    Christine Pirker

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22502340.v1
Abstract
No abstract available
Keywords
  • SIGNATURE (TOPOLOGY)
  • PROTEOME
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.